Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067158 · ClinicalTrials.gov registry record · Phase 3
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
A Phase 3 study, sponsored by New York University.
- Completed
- Registry status
- Phase 3
- Development phase
- 585
- Enrollment target
NCT00067158: Completed Phase 3 study, sponsored by New York University.
NCT00067158 is a Phase 3 study that has completed, run by New York University. The registered enrollment target is 585 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067158, a Phase 3 study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 585 participants
- Enrollment target
Study Summary
The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.
Interventions
- DRUG nicotine transdermal system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2003-04 |
| Est. Completion | 2004-07 |
| Phase | Phase 3 |
What the finished NCT00067158 record still lists
NCT00067158 is an interventional study that assigns participants to a tested intervention. The registered 585 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% lower).
The record links to 0 conditions, and to 1 intervention - of which nicotine transdermal system is the first listed.
NCT00067158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00067158 about?
NCT00067158 is a clinical study titled "Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1". The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.
What is the current status of trial NCT00067158?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 585 participants. The study started on 2003-04. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00067158?
The interventions under investigation include: nicotine transdermal system (DRUG).
Who is sponsoring clinical trial NCT00067158?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00067158's enrollment target sits among peer trials
585 651st of 2000 higher than 1,349 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02803957 · 585 participants · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
- NCT06680869 · 585 participants · Phase 3
Early Amiodarone in Shockable Cardiac Arrest
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia